Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial)
Colorectal Disease · 2025-05 · 27 (5)
DOI: 10.1111/codi.70119 ↗At a glance
Randomisierte kontrollierte Studie in Colorectal Disease, published online on 2025-05-25. Written by Jean-Baptiste Pretalli and 10 co-authors. Institution: Department of Digestive Surgical Oncology-Liver Transplantation Unit, University Hospital of Besançon, Besançon, France. Major MEDLINE topics: Anastomotic Leak, Colorectal Neoplasms, Fluorescein Angiography, Indocyanine Green. Cited 7 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Programme Hospitalier de Recherche Clinique-Cancer, French Ministry of Health.
Abstract (original language)
Aim
Anastomotic leak (AL) is a major problem in colorectal surgery, and its prevention is crucial for patient safety. The scientific literature shows that optimal anastomotic perfusion is essential for anastomotic healing. However, in cases of left colon or rectal cancer requiring high vessel ligation for oncological reasons, anastomotic blood supply relies mainly on the pericolic arterial arcades. Consequently, assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green might be relevant to reduce the risk of AL. Although evidence of its positive impact on the risk of AL is growing in the literature, most studies are descriptive prospective cohorts or retrospective comparative series with controversial findings. Furthermore, no other studies specifically address left‐sided colon or high rectal tumours. FLUOCOL‐1 is a large multicentre randomized controlled trial (RCT) that aims to demonstrate that assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in left‐sided or high anterior resections with intraperitoneal anastomosis Method FLUOCOL‐1 is a French multicentre, single‐blind, randomized, two‐arm, phase III superiority clinical trial. Patients will be randomized in a 1:1 ratio to either the intervention group (FLUO+) or the control group (FLUO−). A total of 1010 patients will be randomized. The primary endpoint is the occurrence of an AL within 90 days postsurgery. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed by imaging or surgical exploration, or any isolated pelvic organ‐space infection with no evidence of fistula, as defined by the International Study Group of Rectal Cancer.
Discussion
Prevention of AL is one of the most important questions to be addressed in colorectal surgery. The FLUOCOL‐1 multicentre RCT described herein aims to demonstrate that assessment of anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in certain resections with intraperitoneal anastomosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Digestive Surgical Oncology-Liver Transplantation Unit, University Hospital of Besançon, Besançon, France.
- INSERM CIC 1431, Centre d'Investigation Clinique, University Hospital of Besançon, Besançon, France.
- Methodology and Quality of Life Unit in Oncology, University of Besançon, Besançon, France.
- INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
- Délégation à la Recherche Clinique et à l'Innovation, University Hospital of Besançon, Besançon, France.
- Department of Pharmacy, University Hospital of Besançon, Besançon, France.
ORCID profiles: Jean-Baptiste Pretalli, Dewi Vernerey, Astrid Pozet, Anne-Laure Clairet, Stéphane Benoist, Mehdi Karoui, Eddy Cotte, Bruno Heyd, Zaher Lakkis
Funding
- Programme Hospitalier de Recherche Clinique-Cancer
- French Ministry of Health
Cite
APA
Pretalli, J. B., Vernerey, D., Evrard, P., Pozet, A., Clairet, A. L., Benoist, S., Karoui, M., Cotte, E., Heyd, B., Lakkis, Z., & FLUOCOL Study Group (2025). Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial). Colorectal Disease, 27(5). https://doi.org/10.1111/codi.70119
Vancouver
Pretalli JB, Vernerey D, Evrard P, Pozet A, Clairet AL, Benoist S, et al. Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial). Colorectal Disease. 2025;27(5). doi:10.1111/codi.70119
BibTeX
@article{Pretalli2025,
author = {Pretalli, Jean-Baptiste and Vernerey, Dewi and Evrard, Philippe and Pozet, Astrid and Clairet, Anne-Laure and Benoist, Stéphane and Karoui, Mehdi and Cotte, Eddy and Heyd, Bruno and Lakkis, Zaher and FLUOCOL Study Group, FLUOCOL Study Group},
title = {Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single‐blind phase III multicentre randomized controlled trial ( FLUOCOL ‐01/ FRENCH 21/ GRECCAR 19 intergroup trial)},
journal = {Colorectal Disease},
year = {2025},
volume = {27},
number = {5},
doi = {10.1111/codi.70119}
}
EUVIMED